Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Alliance Grants

University of Western Ontario

$224,196.00

Scalable purification of heterologously expressed SARS-CoV-2 proteins in the microalgae Phaeodacytlum tricornutum

EF 2021-22

Résumé
The COVID-19 pandemic has highlighted the need for reliable, accurate and cheap diagnostic tests to determine the extent of exposure to the SARS-CoV-2 virus, the causative agent of COVID-19. In particular, serological testing can identify on an individual basis who has been exposed to the SARS-CoV-2 virus and monitor immunological response to vaccination in the Canadian population. A key requirement in developing serological tests is the need for SARS-CoV-2 protein (or antigen) that is immunologically reactive with human antibodies. The goal of the partnership between The University of Western Ontario, Lambton College, Suncor Energy, Lumivi and Pond Technologies is to develop a scalable orthogonal protein-production system for COVID-19 antigens in the microalage, Phaeodactylum tricornutum, for diagnostic purposes and for use in basic science investigations of the SARS-CoV-2 virus. Current protein production systems for COVID-19 antigen are expensive and difficult to scale to meet the requirements of population-level testing, or cannot produce the antigens in an immunologically reactive form. Phaeodactylum tricornutum is a genetically tractable organism, grows in a simple, cheap and defined media (essentially seawater and sunlight), and is currently cultivated in very large volumes for harvesting of bioproducts for human consumption. Coupled with the finding that Phaeodactylum tricornutum can produce proteins that are recognized by the human immune system, these characteristics make it an excellent orthogonal platform for the production of COVID-19 antigens. There is a good chance that SARS-CoV-2 will be a continual threat for years and that it will mutate. In addition, SARS-CoV-2 immunity tends not to be long-lasting, and eradication will require long-term contact tracing and multiple exposure monitoring worldwide by serological testing. The Phaeodactylum tricornutum production system we are proposing will be rapidly modifiable and scalable to respond to these eventualities, and to the emergence of other viral pandemic outbreaks.
Programme
Alliance Grants
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
565307-2021
Name nom
Edgell, David
Department département
Biochemistry
Organization id
36
Institution établissement
University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2021
Award amount
224196
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5300
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Molecular biology
Research subject fr
Biologie moléculaire
Installment
inst:1
Partie
1
Nb partie
2
Application title
Scalable purification of heterologously expressed SARS-CoV-2 proteins in the microalgae Phaeodacytlum tricornutum
Keyword
NSERC
Application summary
The COVID-19 pandemic has highlighted the need for reliable, accurate and cheap diagnostic tests to determine the extent of exposure to the SARS-CoV-2 virus, the causative agent of COVID-19. In particular, serological testing can identify on an individual basis who has been exposed to the SARS-CoV-2 virus and monitor immunological response to vaccination in the Canadian population. A key requirement in developing serological tests is the need for SARS-CoV-2 protein (or antigen) that is immunologically reactive with human antibodies. The goal of the partnership between The University of Western Ontario, Lambton College, Suncor Energy, Lumivi and Pond Technologies is to develop a scalable orthogonal protein-production system for COVID-19 antigens in the microalage, Phaeodactylum tricornutum, for diagnostic purposes and for use in basic science investigations of the SARS-CoV-2 virus. Current protein production systems for COVID-19 antigen are expensive and difficult to scale to meet the requirements of population-level testing, or cannot produce the antigens in an immunologically reactive form. Phaeodactylum tricornutum is a genetically tractable organism, grows in a simple, cheap and defined media (essentially seawater and sunlight), and is currently cultivated in very large volumes for harvesting of bioproducts for human consumption. Coupled with the finding that Phaeodactylum tricornutum can produce proteins that are recognized by the human immune system, these characteristics make it an excellent orthogonal platform for the production of COVID-19 antigens. There is a good chance that SARS-CoV-2 will be a continual threat for years and that it will mutate. In addition, SARS-CoV-2 immunity tends not to be long-lasting, and eradication will require long-term contact tracing and multiple exposure monitoring worldwide by serological testing. The Phaeodactylum tricornutum production system we are proposing will be rapidly modifiable and scalable to respond to these eventualities, and to the emergence of other viral pandemic outbreaks.